The regulation of TSC22D4 in response to tumour stress and its implications in liver cell metabolism might thereby exemplify a common transcriptional node in the documented link between obesity-related dyslipidemia and an increased risk for certain cancer entities (Grote et al, 2010). Here, TSC22D4 is linked to metabolic syndrome.